Navigation Links
Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
Date:5/3/2010

NASHVILLE, Tenn., May 3 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it will report first quarter 2010 financial results after the market closes on Thursday, May 13, 2010.  A conference call and live Internet webcast will be held on Thursday, May 13, 2010 at 5:00 p.m. Eastern Time to discuss the results.

To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers).  A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 800-642-1687 (for U.S. callers) or 706-645-9291 (for international callers).  The Conference ID for the rebroadcast is 72042780.  The live webcast and rebroadcast can be accessed via Cumberland's website at http://investor.shareholder.com/cpix/events.cfm.

Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland markets Acetadote® for the treatment of acetaminophen poisoning and Kristalose®, a prescription laxative. The Company also recently launched Caldolor'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
2. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
3. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
4. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
5. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
6. Althea Technologies Acquires Altus Pharmaceuticals(R) Assets and IP Portfolio, Establishing Technology Platform for Protein Formulations.
7. Addex Pharmaceuticals to Present at BIO Business Forum During the Chicago BIO Convention, May 3rd - 6th, 2010
8. Savient Pharmaceuticals To Hold First Quarter 2010 Results
9. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
10. Lotus Pharmaceuticals Laevo-Bambuterol Received SFDA Approval to Commence Clinical Trials
11. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... -- Finesse expands office in Leicester, United Kingdom ... of its operations in Leicester , ... for customers is expected shortly afterward. With ... the current office, the new premises will double the ... Finesse to bring on more service personnel. The new ...
(Date:2/26/2015)...  Today the National Safety Council released ... side effects of pain medications , ... and Oxycontin, are safer options than over-the-counter pain relievers. ... than on heroin and cocaine combined," said Deborah ... these medications are marketed as the Cadillac option for ...
(Date:2/26/2015)... Feb. 26, 2015 Legislation passed today by ... provision to help prevent inappropriate prescriptions in Medicare Part ... the Integrity of Medicare Act (PIMA) of 2014 , ... Kevin Brady (R-TX) and Ranking Member Jim McDermott ... abuse epidemic and implement the right policies, said the ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2
... Oct. 5, 2011 Sanofi (EURONEXT: SAN and NYSE: ... today the publication of the pivotal Phase III TEMSO ... The New England Journal of Medicine (NEJM).  Results ... the annual relapse rate, reduced disability progressions and improved ...
... HOUSTON, Oct. 5, 2011 Cyberonics, Inc. (NASDAQ: ... for the treatment and management of epilepsy, today announced ... Inc. ("ImThera").  Based in San Diego, California, ImThera is ... for the treatment of obstructive sleep apnea ("OSA"). ...
Cached Medicine Technology:Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio™(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity 2Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio™(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity 3Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio™(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity 4Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio™(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity 5Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio™(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity 6Cyberonics Announces Investment in ImThera Medical 2Cyberonics Announces Investment in ImThera Medical 3Cyberonics Announces Investment in ImThera Medical 4
(Date:2/27/2015)... Sunnyvale, CA (PRWEB) February 27, 2015 ... showcase ClinCapture, its validated Electronic Data Capture (EDC) at ... Francisco, California on March 2nd and March 3rd at ... a self-service platform and DIY CRF and edit-check builder ... Checks in a matter of days, without any programming ...
(Date:2/27/2015)... 2015 Altec Products, Inc., announced today ... ERP Document Management Partner of the Year. ADSS Global ... and other complimentary solutions for their customers across the ... many years to provide clients with paperless solutions that ... “We are thrilled to recognize ADSS Global for their ...
(Date:2/27/2015)... In honor of American Heart Month in February, ... office, is offering tips on how to improve heart health. , ... doesn't mean people have to accept it as their fate. Although ... such as family history, sex or age — there are some ... has six helpful tips to improve heart health and prevent heart ...
(Date:2/27/2015)... 2015 Undocumented farmworkers are half ... use Medicaid, the federal health insurance program available ... new study from UC Davis Health System. The ... farmworker use of Medicaid, which provides coverage for ... status, was having children. , “Undocumented agricultural ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The federal ... ) that allege use of the statin medication can ... has issued a new order pertaining discovery in the ... Bernstein Liebhard LLP comments. The Order, which was issued ... on February 25th, directs the parties to schedule certain ...
Breaking Medicine News(10 mins):Health News:Clinovo to Demo Its Self-Service, Cloud-Based EDC Solution at CALBIO2015 on March 2nd and 3rd, 2015 2Health News:Altec Announces 2014 Sage ERP Document Management Partner of the Year Award Recipient 2Health News:Center for Primary Care Celebrates American Heart Month 2Health News:Center for Primary Care Celebrates American Heart Month 3Health News:Center for Primary Care Celebrates American Heart Month 4Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 2Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 3Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3
... While the visual regions of the brain have been ... uncharted territory. Now, researchers at the Hebrew University of ... a key auditory process perceiving sound space, the ... concentrating on those sounds. , The findings settle ...
... MEDIA, Pa., Sept. 20 Synova Healthcare Group,Inc. (OTC ... sale,of approximately $3.3 million in aggregate notional principal amount ... September 19, 2012,and related common stock purchase warrants. This ... private placement of notes and warrants in the,aggregate notional ...
... Philadelphia, PA, September 20, 2007 Pedophilia, the sexual ... health concern and it does not respond well to ... not well understood. A new study being published ... the first of its kind to use functional brain ...
... Calif., Sept. 20 Cardiva Medical, Inc.,a privately ... Chairman and CEO, will present at the UBS ... in New York City. Notably, the,company will be ... the,Boomerang Catalyst II System, which recently received a ...
... 19, 2007 -- A single dose of Otsukas ... resulted in favorable changes in hemodynamics associated with ... with advanced heart failure (ADHF) who participated in ... HemodynamIc Parameters in Subjects with HEart failure (ECLIPSE), ...
... Speaker Nancy Pelosi,issued the following statement today on ... a vote of 405 to 7:, "Today,s sweeping, ... all Americans., "Essential to the safety net of ... that the prescription drugs they buy are safe. These ...
Cached Medicine News:Health News:Sensitivity of brain center for 'sound space' defined 2Health News:Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants 2Health News:Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants 3Health News:Pedophilia patients are found to have deficits in brain activation 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 3Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 4Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 5Health News:ECLIPSE data on effects of Otsuka's investigational novel treatment, Tolvaptan 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: